ADDITION OF FELODIPINE TO METOPROLOL VS REPLACEMENT OF METOPROLOL BY FELODIPINE IN PATIENTS WITH ANGINA-PECTORIS DESPITE ADEQUATE BETA-BLOCKADE - RESULTS OF THE FELODIPINE ER AND METOPROLOL CR IN ANGINA (FEMINA) STUDY
P. Dunselman et al., ADDITION OF FELODIPINE TO METOPROLOL VS REPLACEMENT OF METOPROLOL BY FELODIPINE IN PATIENTS WITH ANGINA-PECTORIS DESPITE ADEQUATE BETA-BLOCKADE - RESULTS OF THE FELODIPINE ER AND METOPROLOL CR IN ANGINA (FEMINA) STUDY, European heart journal, 18(11), 1997, pp. 1755-1764
Aims The study aimed to compare the addition of felodipine to metoprol
ol, and of the replacement of metoprolol by felodipine, with continuat
ion of metoprolol, in patients with angina pectoris despite optimal be
ta-blockade. Methods and results The study was double-blind, parallel,
randomized and controlled, and comprised 363 patients from 27 outpati
ent cardiology clinics in the Netherlands. The patients had angina and
positive bicycle exercise tests despite optimal beta-blockade (restin
g heart rate < 65 beats.min(-1)). Randomization waste three treatment
groups: continuation of metoprolol (control), addition of felodipine t
o metoprolol, and replacement of metoprolol by felodipine. Exercise te
sts were repeated after 2 and 5 weeks. The main outcome measure was: e
xercise result after 5 weeks, compared with baseline, between-group co
mparison of changes vs control. There were no significant differences
in exercise duration and onset of chest pain vs control. The addition
of felodipine increased time until 1 mm ST depression (43 s, 95% confi
dence interval 20-65 s), and decreased both ST depression at highest c
omparable work load (0.46 mm, 95% confidence interval 0.19-0.72), and
maximal ST depression (0.49mm, 95% confidence interval 0.23-0.74). Exe
rcise results after replacement of metoprolol by felodipine were not d
ifferent from control, apart from a significant increase in rate press
ure product. Significantly more patients experienced adverse events in
the felodipine monotherapy group. Conclusion Combination of metoprolo
l and felodipine is to be preferred to felodipine monotherapy in patie
nts who have signs and symptoms of myocardial ischaemia despite optima
l beta-blockade.